287 related articles for article (PubMed ID: 21081714)
1. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.
Xing Y; Bronstein Y; Ross MI; Askew RL; Lee JE; Gershenwald JE; Royal R; Cormier JN
J Natl Cancer Inst; 2011 Jan; 103(2):129-42. PubMed ID: 21081714
[TBL] [Abstract][Full Text] [Related]
2. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
[TBL] [Abstract][Full Text] [Related]
3. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.
Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A; Espinosa N; Moreno-Ramírez D; Giavedoni P; Vilana R; Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S
J Am Acad Dermatol; 2019 Dec; 81(6):1330-1338. PubMed ID: 31163236
[TBL] [Abstract][Full Text] [Related]
6. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
8. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
[TBL] [Abstract][Full Text] [Related]
9. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Veit-Haibach P; Vogt FM; Jablonka R; Kuehl H; Bockisch A; Beyer T; Dahmen G; Rosenbaum S; Antoch G
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):910-8. PubMed ID: 19156409
[TBL] [Abstract][Full Text] [Related]
11. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
12. Use of Preoperative PET/CT Staging in Sentinel Lymph Node-Positive Melanoma.
Scheier BY; Lao CD; Kidwell KM; Redman BG
JAMA Oncol; 2016 Jan; 2(1):136-7. PubMed ID: 26401901
[No Abstract] [Full Text] [Related]
13. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
18. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Value of PET/CT Imaging in Melanoma Groin Metastases.
van Wissen J; van der Hiel B; van der Hage JA; van de Wiel BA; Wouters MW; van Akkooi AC
Ann Surg Oncol; 2016 Jul; 23(7):2323-9. PubMed ID: 26920386
[TBL] [Abstract][Full Text] [Related]
20. Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases.
Aukema TS; Valdés Olmos RA; Wouters MW; Klop WM; Kroon BB; Vogel WV; Nieweg OE
Ann Surg Oncol; 2010 Oct; 17(10):2773-8. PubMed ID: 20422454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
